pocketful logo light
pocketful logo light
IPO Logo

Avience Biomedicals Ipo

SMEClosed
385.32x
Subscribed

Avience Biomedicals Ipo Details

Bidding date

18 - 22 Jun 26

Minimum investment

₹2,49,600

Lot size

1,200

Price range

₹196 - ₹208

Issue size

14.54 L Shares

IPO doc

RHP PDF

Allotment date

23 Jun 26

IPO Status

Offer start

18 Jun 26

Offer end

22 Jun 26

Allotment

23 Jun 26

Refund initiation

24 Jun 26

Demat transfer

24 Jun 26

Listing

25 Jun 26

Subscription Rate

Investor CategorySubscription Rate
QIB (Excl. Anchor)196.77x
NII597.23x
NII (Above 10L)451.35x
Individual Investors401.36x
Total Subscription385.32x
About the company

Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry. Avience Biomedicals Limited has expanded its product range from IVD rapid test kits to a comprehensive line of medical devices, including serology products and biochemistry analyzers. This demonstrates a commitment to diverse healthcare needs, focusing exclusively on the B2B and B2G markets. The company's products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas. In addition to manufacturing, the Company also act as distributors and traders of medical equipment. The company's manufacturing unit is situated in Noida, Uttar Pradesh. The company offers a comprehensive range of diagnostic solutions, including: As of January 31, 2026, the company had 75 permanent employees and 33 contractual employees

Issue size

Funds Raised in the IPOAmount
Overall Issue Size₹30.24 Cr
Reserved for Market Maker₹1.71 Cr
Net Offer to Public

Open Your Free Demat Account

Enter your phone number